Meta-analysis of the prevalence, incidence and natural history of critical limb ischemia

Journal of Cardiovascular Surgery

Volumn 54, Issue 6, 2013, Pages 663-669

  Biancari, F ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Aged; Ischemia; Peripheral arterial disease

Indexed keywords

AMPUTATION; AMPUTATION FREE SURVIVAL; ANKLE BRACHIAL INDEX; ANKLE PRESSURE; ARTICLE; CONSERVATIVE TREATMENT; CRITICAL LIMB ISCHEMIA; FONTAINE; GANGRENE; HISTORY; HUMAN; ICD-9-CM; INCIDENCE; LEG ISCHEMIA; LEG ULCER; MEDICARE; META ANALYSIS; PAIN; POPULATION; PREVALENCE; REST; REST PAIN; REVASCULARIZATION; SURVIVAL; SYSTEMATIC REVIEW; HEALTH; ISCHEMIA; LEG; REVIEW; RISK ASSESSMENT; RISK FACTOR; VASCULAR SURGERY; VASCULARIZATION;

HUMANS; INCIDENCE; ISCHEMIA; LOWER EXTREMITY; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; VASCULAR SURGICAL PROCEDURES; WORLD HEALTH; GLOBAL HEALTH;

EID: 84891539360     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Barshes NR, Belkin M, on behalf of the MOVIE Study Collaborators. A framework for the evaluation of "value" and cost-effectiveness in the management of critical limb ischemia. J Am Coll Surg 2011;213:552-66.
2. Romiti M, Albers M, Brochado-Neto FC, Durazzo AES, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008;47:975-81.
3. Rollins KE, Jackson D, Coughlin PA. Meta-analysis of contemporary short- and long-term mortality rates in patients diagnosed with critical leg ischemia. Br J Surg 2013;100:1002-8.
4. Biancari F, Arvela E, Korhonen M, Söderström M, Söderström M, Halmesmäki K, Albäck A et al. End-stage renal disease and critical limb ischemia: a deadly combination? Scand J Surg 2012;101:138-43.
5. Teraa M, Sprengers RW, van der Graaf Y, Peters CE, Moll FL, Verhaar MC. Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials. Ann Surg 2013 [In press].
6. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16.
7. Fowkes FG, Murray GD, Butcher I, Butcher I, Heald CL, Lee RJ et al. Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300:197-208. (Pubitemid 351969304)
8. Kröger K, Stang A, Kondratieva J, Moebus S, Beck E, Schmermund A et al. Prevalence of peripheral arterial disease - results of the Heinz Nixdorf recall study. Eur J Epidemiol 2006;21:279-85. (Pubitemid 43725485)
9. Jensen SA, Vatten LJ, Myhre HO. The prevalence of chronic critical lower limb ischemia in a population of 20000 subjects 40-69 years of age. Eur J Vasc Endovasc Surg 2006;32:60-5. (Pubitemid 43842750)
10. Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 2007;45:1185-91. (Pubitemid 46817840)
11. He Y, Jiang Y, Wang J, Fan L, Li X, Hu FB. Prevalence of peripheral arterial disease and its association with smoking in a population-based study in Beijing, China. J Vasc Surg 2006;44:333-8. (Pubitemid 44142914)
12. Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005;366:1773- 83.
13. Baser O, Verpillat P, Gabriel S, Wang L. Prevalence, incidence, and outcomes of critical limb ischemia in the US Medicare population. Vasc Dis Manag 2013;10:26-36.
14. Lepäntalo M, Mätzke S. Outcome of unreconstructed chronic critical leg ischaemia. Eur J Vasc Endovasc Surg 1996;11:153-7. (Pubitemid 26120467)
15. Brosi P, Dick F, Do DD, Schmidili J, Baumgartner I, Diehm N. Revascularization for chronic critical lower limb ischemia in octogenarians is worthwhile. J Vasc Surg 2007;46:1198-207.
16. Shah AP, Klein AJ, Sterrett A, Messenger JC, Albert S, Nehler MR et al. Clinical outcome using aggressive approach to anatomic screening and endovascular revascularization in a Veterans Affairs population with critical limb ischemia. Catheter Cardiovasc Interv 2009;74:11-9.
17. Scatena A, Petruzzi P, Ferrari M, Rizzo L, Cicorelli A, Berchiolli R et al. Outcomes of three years of teamwork on critical limb ischemia in patients with diabetes and foot lesions. Int J Low Extrem Wounds 2012;11:113-9.
18. Varty K, Nydahl S, Butterworth P, Errington M, Bolia A, Bell PR et al. Changes in the management of critical limb ischaemia. Br J Surg 1996;83:953-6. (Pubitemid 26228214)
19. Awad S, Karkos CD, Serrachino-lnglott F, Cooper NJ, Butterfield JS, Ashleigh R et al. The impact of diabetes on current revascularisation practice and clinical outcome in patients with critical lower limb ischaemia. Eur J Vasc Endovasc Surg 2006;32:51-9. (Pubitemid 43842748)
20. Engelhardt M, Boos J, Bruijnen H, Wohlgemuth W, Willy C, Tannheimer M et al. Critical limb ischaemia: initial treatment and predictors of amputation-free survival. Eur J Vasc Endovasc Surg 2012;43:55-61.
21. Bailey CMH, Saha S, Magee TR, Galland RB. A 1 year prospective study of management and outcome of patients presenting with critical lower limb ischemia. Eur J Vasc Endovasc Surg 2003;25:131-4. (Pubitemid 36519594)
22. de Leur K, van Zeeland ML, Ho GH, de Groot HG, Veen EJ, van der Laan L. Treatment for critical lower limb ischemia in elderly patients. World J Surg 2012;36:2937-43.
23. Ubbink DT, Spincemaille GHJJ, Reneman RS, Jacobs MJHM. Prediction of imminent amputation in patients with non-reconstructable leg ischemia by means of microcirculatory investigations. J Vasc Surg 1999;30:114-21. (Pubitemid 29340626)
24. Klomp HM, Spincemaille GH, Steyerberg EW, Habbema JD, van Urk H. Spinal-cord stimulation in critical limb ischemia: a randomised trial. ESES Study Group. Lancet 1999;353:1040-4. (Pubitemid 29149911)
25. Amann W, Berg P, Gersbach P, Gamain J, Raphael JH, Ubbink DT; European Peripheral Vascular Disease Outcome Study SCS-EPOS. Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS). Eur J Vasc Endovasc Surg 2003;26:280-6. (Pubitemid 37021368)
26. Marston WA, Davies SW, Armstrong B, Farber MA, Mendes RC, Fulton JJ et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg 2006;44:108-14.
27. Belch J, Hiatt WR, Baumgartner I, Driver IV, Nikol S, Norgren L et al. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 2011;377:1929-37.
28. Benoit E, O'Donnell TF Jr, Iafrati MD, Asher E, Bandyk DF, Hallett JW et al. The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design. J Transl Med 2011;9:165.
29. Powell RJ, Marston WA, Berceli SA, Guzman R, Henry TD, Longcore AT et al. Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial. Mol Ther 2012;20:1280-6.
30. Losordo DW, Kibbe MR, Mendelsohn F, Marston W, Driver VR, Sharafuddin M et al. A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia. Circ Cardiovasc Interv 2012;5:821-30.
31. Jivegård LE, Augustinsson LE, Holm J, Risberg B, Ortenwall P. Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a prospective randomised controlled study. Eur J Vasc Endovasc Surg 1995;9:421-5.
32. Becker F, Robert-Ebadi H, Ricco JB, Setacci C, Cao P, de Donato G et al. Chapter I: Definitions, epidemiology, clinical presentation and prognosis. Eur J Vasc Endovasc Surg 2011;42(Suppl 2):S4-12.
33. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG et al. Inter-Society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007;33(Suppl 1):S1-75.
34. Elgzyri T, Larsson J, Thörne J, Eriksson KF, Apelqvist J. Outcome of ischemic foot ulcer in diabetic patients who had no invasive vascular intervention. Eur J Vasc Endovasc Surg 2013;46:110-7.
35. Martini R, Andreozzi GM, Deri A, Cordova R, Zulian P, Scarpazza O et al. Amputation rate and mortality in elderly patients with critical limb ischemia not suitable for revascularization. Aging Clin Exp Res 2012;24 (Suppl. 3):24-7.
36. Barshes NR, Chambers JD, Cohen J, Belkin M; Model To Optimize Healthcare Value in Ischemic Extremities 1 (MOVIE) Study Collaborators. Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss. J Vasc Surg 2012;56:1015-24.
37. Benoit E, O'Donnell TF Jr, Kitsios GD, Iafrati MD. Improved amputation-free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement. J Vasc Surg 2012;55:781-9.